Sign in

Gianluca Matteoli

@gianlucamatteoli.bsky.social
431 followers 1.3K following 16 posts

Prof. Gianluca Matteoli PI Mucosal Immunology lab Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven Advancing innovative therapies for IBD by unraveling stromal-immune system interactions.

PostsRepliesMedia
Gianluca Matteoli @gianlucamatteoli.bsky.social · 15/10/2025
We're hiring! 🧪 TARGID @ KU Leuven is looking for a Laboratory Manager to coordinate and support cutting-edge research on gastrointestinal diseases. 📍Leuven | ⏰ Apply by Nov 4, 2025 🔗 kuleuven.be/personeel/jobsite/jobs/60566238 #KULeuven #Hiring #Research
kuleuven.be
Laboratoriummanager
TARGID zoekt een enthousiaste laboratoriumtechnoloog.
032
Reposted by Gianluca Matteoli
FIBROTARGET @fibrotarget.bsky.social · 21/08/2025
Looking for reliable information on fibrosis? The FIBROTARGET factsheet is now available in English, Dutch, Spanish, German, French & Italian! Access key insights on IBD-related fibrosis, created with and for the community in partnership with IFCCA! Download your copy 👉 loom.ly/yW8mEBc
011
Reposted by Gianluca Matteoli
PasciutoLab @pasciutolab.bsky.social · 19/05/2025
NIM lab is growing! 🧠🔬 We are hiring a flow cytometry specialist, a bioinformatician and a post-doc candidate! Join us or help spread the word: - jobs.vib.be/j/113480/flo... - jobs.vib.be/j/113083/bio... - www.uantwerpen.be/en/jobs/vaca...
0108
Reposted by Gianluca Matteoli
European Commission @ec.europa.eu · 14/05/2025
Every €1 the EU invests in research can yield up to €11 in growth by 2045. With €43 billion from Horizon Europe, we’ve backed 15,000+ projects – from antibiotics to the transition. This year we’ll put in over €7.3 billion to meet Europe’s challenges. For everyone to benefit ↓ europa.eu/!WHpGGg
A stylised image on a dark blue background, with "€1 invested in research," alongside a hand wearing a light blue glove holding a stylised euro. On the right-hand side is the text, "€11 in economic growth by 2045," with another gloved hand placing a pile of stylised coins. In the bottom right corner sits the emblem of the European Union.
1333369
Gianluca Matteoli @gianlucamatteoli.bsky.social · 11/05/2025
Delighted to join the International Conference on Complement Therapeutics @aegeanconf.bsky.social — a fantastic setting to hear from pioneers like John Lambris on development of complement-targeted therapies. We will present our latest data on the role of complement in IBD @fibrotarget.bsky.social
040
Reposted by Gianluca Matteoli
Malinda Lo @malindalo.bsky.social · 14/04/2025
Harvard redid its whole homepage to push back against the administration’s demands. I mean, this is just a website but I think it’s kind of a great PR move: www.harvard.edu
harvard.edu
Harvard University
Harvard University is devoted to excellence in teaching, learning, and research, and to developing leaders who make a difference globally.
11269491487
Reposted by Gianluca Matteoli
Trends in Neurosciences @cp-trendsneuro.bsky.social · 08/04/2025
April 2025 issue of Trends in Neurosciences: www.cell.com/issue/S0166-... Free featured articles & more: cell.com/trends/neuro... Cover article: ‘MicroRNA regulation of enteric nervous system development and disease’ by Holland et al., @wboesmans.bsky.social group www.cell.com/trends/neuro...
0133
Gianluca Matteoli @gianlucamatteoli.bsky.social · 28/03/2025
Fantastic story showcasing the full strength of @KU_Leuven — from cutting-edge basic science to real-world exploitation. A true example of how academic excellence can drive meaningful impact on health! @kuleuvenuniversity.bsky.social
010
Reposted by Gianluca Matteoli
Motilent @motilent.bsky.social · 14/03/2025
Buongiorno from the @fibrotarget.bsky.social General Assembly meeting in Milan! It’s been an exciting start to the meeting we’ve already covered advancements in #fibrosis biomarker characterisation, imaging and how to quantify this and began laying the foundation for an upcoming clinical trial!
001
Reposted by Gianluca Matteoli
FIBROTARGET @fibrotarget.bsky.social · 23/01/2025
FIBROTARGET aims to make progress in fibrosis & fibrostenosis research, and encourages patients to join this journey. Stay informed with our factsheets in 6 different languages! 💡 Learn more: [loom.ly/yW8mEBc] #IBD #FIBROTARGET #PatientImpact #Fibrosis
021
Reposted by Gianluca Matteoli
FIBROTARGET @fibrotarget.bsky.social · 14/03/2025
FIBROTARGET GAM: Day 1 at Humanitas University in Milan Day 1 highlights: ✅ Patient insights from EFCCA ✅ New fibrosis biomarker research 🔬 ✅ Cutting-edge imaging 🏥 ✅ Laying the groundwork for a clinical trial 🏆 More soon—stay tuned! 🔍
033
Reposted by Gianluca Matteoli
FIBROTARGET @fibrotarget.bsky.social · 14/03/2025
💫 After two days of insightful discussions, strategic planning, and key project updates, the 3rd FIBROTARGET General Assembly Meeting in Milan is a wrap! 🇮🇹 A huge thank you to everyone who contributed to this productive and inspiring meeting! 🤝🚀 #FIBROTARGET #Collaborativeresearch #HorizonEurope
042
Reposted by Gianluca Matteoli
Ursula von der Leyen @vonderleyen.ec.europa.eu · 08/03/2025
Gender equality doesn’t just 'happen.' Women’s rights must be fought for and protected. Our responsibility is clear. To lead by example and create a world where opportunities are fair for all. Not just today, but every single day. #InternationalWomensDay
16363201679
Reposted by Gianluca Matteoli
Eric Topol @erictopol.bsky.social · 01/03/2025
Francis Collins, the NIH Director for 12 years, led the Human Genome Project and other NIH efforts for 32 years, resigned today. Key words from his resignation letter www.nytimes.com/2025/03/01/u...
6131251381
Reposted by Gianluca Matteoli
Nature @nature.com · 27/02/2025
Nature research paper: Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses go.nature.com/3XmyOPD
go.nature.com
Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses - Nature
Phagocytosed bacteria can serve as an alternative nutrient source for macrophages, influencing their metabolic and immune responses through the recycling of microbial components, with the process regulated by nutrient-sensing mechanisms and bacterial viability.
16925
Reposted by Gianluca Matteoli
Lars Vereecke @larsvereecke.bsky.social · 09/01/2025
🚨 Join the 5th GGIG Meeting on 15-16 May 2025 in Ghent, highlighting the latest advances in intestinal biology & host-microbe interactions. Honoured to have Prof. Emma Slack as keynote speaker, and may top-stories from leading scientists in the field. 🦠🔬 www.vibconferences.be/events/5th-g...
vibconferences.be
5th Ghent Gut Inflammation Group Meeting
15-16 May 2025, Ghent, Belgium Host-microbiota interactions in health and disease
031
Reposted by Gianluca Matteoli
Mucosal Immunology @mucosalimmunol.bsky.social · 24/02/2025
It’s #MucosalMonday and time for another Mucosal Immunology Podcast episode! This month Cecilia Muglia discusses how colonic polyps in pediatric patients are handled - and what they mean for food allergy. Find it on your favorite platform, including: www.iheart.com/podcast/269-...
iheart.com
Mucosal Immunology Podcast | iHeart
Enjoy enlightening podcasts designed to keep the scientific community up to date with the latest breakthroughs in mucosal immunology. Each episode features cutting-edge research from the Mucosal Immun...
066
Reposted by Gianluca Matteoli
Kathryn Knoop, PhD @kknoop.bsky.social · 24/02/2025
Come along for a fantastic feature interview hosted by @marionbrunck.bsky.social, another medical mystery @ashu-mangalam.bsky.social, and the latest #EmergingLeadersinMI research! #MucosalMonday
053
Gianluca Matteoli @gianlucamatteoli.bsky.social · 16/02/2025
🎉 600 Years of Excellence: KU Leuven 🎓🌌 This year, KU Leuven celebrates an extraordinary milestone: 600 years of knowledge, innovation, and impact. For six centuries, our university has been at the forefront of education, research, and societal advancement.
161
Reposted by Gianluca Matteoli
GuccioneLab @guccionelab.bsky.social · 12/02/2025
What an amazing cover! Congrats @gloglita.bsky.social
241
Reposted by Gianluca Matteoli
European Commission @ec.europa.eu · 11/02/2025
"We aim to mobilise a total of €200 billion for AI investments in Europe. It will be the largest public-private partnership in the world for the development of trustworthy AI." — President @vonderleyen.ec.europa.eu at the Artificial Intelligence Action Summit
1419739
Reposted by Gianluca Matteoli
Adrian Liston @labliston.bsky.social · 07/02/2025
Diversity in Science symposium starting in Leuven!
1377
Reposted by Gianluca Matteoli
Aegean Conferences, Inc. @aegeanconf.bsky.social · 03/02/2025
Deadline Extended to Feb. 15. Abstract Submission and Trainee Award Application - 17th International Conference on #ComplementTherapeutics in #Sissi #Crete #Greece www.aegeanconferences.org/src/App/conf...
011
Reposted by Gianluca Matteoli
United European Gastroenterology @myueg.bsky.social · 30/01/2025
🌟 Transforming the future of Crohn’s disease! UEG is proud to support INTERCEPT IHI project, Europe’s 1st trial using innovative biomarkers to prevent Crohn's before symptoms begin! 🚀 💡 Funded by Innovative Health Initiative - Europe (€38M) 🔗 Learn more: www.intercept-ihi.eu
a group of people standing together
053
Reposted by Gianluca Matteoli
Mucosal Immunology @mucosalimmunol.bsky.social · 27/01/2025
Our brand new Musocal Immunology Podcast is live! Episode 1 features @regisjoulia.bsky.social chatting with @marionbrunck.bsky.social, @ashu-mangalam.bsky.social, and more @societymucosalimm.bsky.social. Available on Spotify, Apple Podcasts, Amazon Music, and iHeart. www.iheart.com/podcast/269-...
0114
Reposted by Gianluca Matteoli
Kathryn Knoop, PhD @kknoop.bsky.social · 27/01/2025
For 2025 I’m adding “Podcast Producer” to my CV! Be sure to download and follow the Mucosal Immunology Podcast from @mucosalimmunol.bsky.social and @societymucosalimm.bsky.social - available on all major podcast platforms.
171
Reposted by Gianluca Matteoli
Nature Portfolio @natureportfolio.nature.com · 24/01/2025
The majority of people who responded to a poll in Nature say they’re now using Bluesky. They’re using it to connect with other scientists, keep up to date with other research or researchers, and promote their own research. 🧪
go.nature.com
Bluesky’s science takeover: 70% of Nature poll respondents use platform
Roughly 6,000 readers answered our poll, with many declaring that Bluesky was nicer, kinder and less antagonistic to science than X.
5411114
Reposted by Gianluca Matteoli
Institut Imagine @institutimagine.bsky.social · 17/01/2025
🚀 Un nouveau chapitre s'ouvre pour l’Institut Imagine ! Nous sommes heureux d’accueillir la Pr Bana Jabri en tant que nouvelle directrice de l’Institut. Pour en savoir plus, consultez le communiqué de presse 👉 www.institutimagine.org/fr/la-profes...
0184
Reposted by Gianluca Matteoli
Adrian Liston @labliston.bsky.social · 17/01/2025
Integral to all strategies here are integrating #equality, #diversity and #inclusion across the organisation. Each place will have unique challenges and history, and while #EDI #hiring is an important first step, it can't be the last. A lead-in pipeline may need to first be built... 6/13
133
Reposted by Gianluca Matteoli
FIBROTARGET @fibrotarget.bsky.social · 17/12/2024
🎉We're proud to announce that FIBROTARGET is now in action🎉 This €6M #HorizonEurope project aims to advance inflammatory bowel disease (#IBD) diagnosis and therapies🔬 You can learn more about the 5-year initiative below on our LIVE website🌐 fibrotarget.eu #fibrosis #fibrostenosis
042
Reposted by Gianluca Matteoli
Itai Yanai @itaiyanai.bsky.social · 29/12/2024
The big 4 of grant writing: 1. Credibility: The topic fits your expertise 2. Narrative: It's clear what is the problem, the solution, and why you’re the right person for it 3. Juicy details: Flex your mastery of the topic 4. The concept: You connect every part to the big question
79418